BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 3
• 4
• 5
• 6
• 7
• 10
• 11
• 12
• 13
• 14
• 17
• 18
• 19
• 20
• 21
• 24
• 25
• 26
• 27
• 28
• 29

• Drug Development

  DOV Pharmaceutical’s Bicifadine Fails To Prove Effective In Phase 3 Trial; Stock Tumbles

  April 25, 2006

   · 

  4 min read
• Policy

  Cephalon, Inc. Provides Update On Regulatory Status Of SPARLON(TM); FDA Delays Decision

  April 25, 2006

   · 

  3 min read
• Policy

  Discovery Laboratories Reports Surfaxin Manufacturing Issue; Drug Approval Delayed

  April 25, 2006

   · 

  1 min read
• Deals

  Abraxis BioScience, Inc. To Acquire European And U.S. Compliant Manufacturing Complex From Pfizer Inc.

  April 25, 2006

   · 

  4 min read
• BioForest

  Cell Therapeutics, Inc. Announces Public Offering Of $33.2 Million In Convertible Senior Notes

  April 25, 2006

   · 

  3 min read
• Business

  Inspire Pharmaceuticals Announces Date For Conference Call And Webcast To Discuss First Quarter 2006 Financial Results

  April 25, 2006

   · 

  1 min read
• Business

  BioElectronics Corporation Announces The Addition Of Dr. Michael Z. Metzger As A Consulting Podiatrist

  April 25, 2006

   · 

  1 min read
• BioForest

  NeoRx Corporation Shareholders Approve Financing Transaction

  April 25, 2006

   · 

  2 min read
• Pharm Country

  Ranbaxy Laboratories Successfully Invalidates Atorvastatin Patent In Austria

  April 25, 2006

   · 

  3 min read
• Business

  Sepracor, Inc. Announces First Quarter 2006 Results

  April 25, 2006

   · 

  1 min read